November/December 2010 Issue
If the serial acquirers dont kill us, theyll make us stronger.
Like Leonardo, weve got great technologies, just not the infrastructure and support for them.
The connection between cGMPs and fraud is difficult, but possible, to make. Expect more people to try.
Where does the American public go when they have questions about their drugs? Apparently not the drug company websites.
A surprisingly small number of corporate projects actually succeedhere's how to increase the odds.
Theres more to serialization than generating numbers and printing them on a label.
Quality systems should grow as your business does.
Applying analytics throughout the organization, rather than in pockets of activity as pharma typically has, can be a catalyst for business performance.